Транексамова Киселина Каби

Tranexamic Acid Каби is an intravenous antifibrinolytic medication used to reduce bleeding by slowing clot breakdown. This EU-manufactured sterile solution supports surgical and trauma-related hemorrhage control. Ideal for patients needing rapid systemic hemostasis. Short-term use under medical supervision.

Tranexamic Acid Каби is commonly used to prevent and reduce excessive bleeding during or after surgeries like cardiac, orthopedic, or gynecological procedures. It is also administered to manage bleeding in trauma cases or conditions causing heavy menstrual flow. Patients with hemophilia may receive it to control bleeding episodes. The medication works by blocking enzymes that dissolve blood clots.

This solution helps maintain stable blood clot formation, reducing the need for transfusions in many cases. Patients often report less bruising or swelling post-surgery when treated with tranexamic acid. Some may experience mild digestive discomfort or headache after administration. Effects vary by individual and medical condition.

Tranexamic Acid Каби should only be used as prescribed by a healthcare professional. Patients with a history of blood clots, kidney disease, or seizures require careful monitoring during treatment. Inform your doctor about all medications and conditions before use. Avoid use if you have active blood clots or color vision disturbances.

Concurrent use with hormonal contraceptives may increase clot risk. Combining with other antifibrinolytics or prothrombin complex concentrates can intensify effects. Alcohol and certain antibiotics may alter how tranexamic acid works in the body. Always disclose all medications to your healthcare provider to prevent potential interactions.